Data Insights

TT-10 by Portage Biotech for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Data Insights

TT-10 by Portage Biotech for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Head And Neck Squamous Cell Carcinoma...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Head And Neck Squamous Cell Carcinoma (HNSC)

Data Insights

TT-10 by Portage Biotech for Metastatic Renal Cell Carcinoma: Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Metastatic Renal Cell Carcinoma. According to...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Metastatic Renal Cell Carcinoma

Data Insights

TT-10 by Portage Biotech for Non-Small Cell Lung Cancer: Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Non-Small Cell Lung Cancer. According to...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Non-Small Cell Lung Cancer

Data Insights

TT-10 by Portage Biotech for Endometrial Cancer: Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Endometrial Cancer

Data Insights

TT-10 by Portage Biotech for Solid Tumor: Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Solid Tumor. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Solid Tumor

Data Insights

TT-10 by Portage Biotech for Head And Neck Cancer: Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Head And Neck Cancer. According to...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Head And Neck Cancer

Data Insights

TT-10 by Portage Biotech for Colorectal Cancer: Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Colorectal Cancer

Data Insights

TT-10 by Portage Biotech for Ovarian Cancer: Likelihood of Approval

TT-10 is under clinical development by Portage Biotech and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Ovarian Cancer